No Data
No Data
Coherus Biosciences Manages UDENYCA Supply Interruption and Cost Reductions
Express News | Coherus BioSciences - Engaged Additional Final Packaging & Labeling Cmo, to Manufacture Udenyca by 2024 End
Express News | Coherus BioSciences Inc - Company Projects That These Actions Will Collectively Reduce Production Cost of Udenyca by Approximately One-Third From Current Levels
Express News | Coherus BioSciences - to Work With Wholesalers & Prescribers to Minimize Any Disruption From Temporary Supply Interruption
Express News | Coherus BioSciences Inc - Projects Channel Supply Udenyca to Be Substantially Depleted by Mid-October as Inventories Draw Down
Express News | Coherus BioSciences: A 3Rd-Party Cmo Said Capacity Constraints at Final Labeling & Packaging Facility to Cause Temporary Udenyca Supply Interruption
No Data
No Data